Clinical Laboratory Improvement Advisory Committee, 9578-9579 [2011-3707]
Download as PDF
<![CDATA[
9578
Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices
Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Conducting
Public Health Research Through the
Field Epidemiology and Laboratory
Training Programs (FETPs/FELTPs),
Funding Opportunity Announcement
(FOA) GH11–001, Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): National Spina
Bifida Patient Registry—Clinic
Demonstration Project (U01), Funding
Opportunity Announcement (FOA)
DD11–001, Initial Review
[FR Doc. 2011–3710 Filed 2–17–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (NCEH/ATSDR);
Notice of National Conversation on
Public Health and Chemical Exposures
Leadership Council Meeting
Time and Date: 8:30 a.m.–5 p.m.,
Friday, March 11, 2011.
Location: Washington Plaza Hotel, 10
Thomas Circle, NW., Washington, DC
20005.
Status: Open to the public, on a first
come, first served basis, limited by the
space available. An opportunity for the
public to listen to the meeting by phone
may be provided; see ‘‘contact for
additional information’’ below.
Purpose: This is the final scheduled
meeting of the National Conversation on
Public Health and Chemical Exposures
Leadership Council. The National
Conversation on Public Health and
Chemical Exposures is a collaborative
initiative through which many
organizations and individuals are
helping develop an action agenda for
strengthening the nation’s approach to
protecting the public’s health from
harmful chemical exposures. The
Leadership Council provides overall
guidance to the National Conversation
project and will be responsible for
issuing the final action agenda. For
additional information on the National
Conversation on Public Health and
Chemical Exposures, visit this Web site:
https://www.atsdr.cdc.gov/
nationalconversation/.
Meeting agenda: The Leadership
Council will finalize the Action Agenda.
Contact for additional information: If
you would like to receive additional
information on attending the meeting or
the potential opportunity to listen to the
meeting by phone, please contact:
nationalconversation@cdc.gov or Julie
Fishman at 770–488–0629.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:30 p.m.–3 p.m., April
13, 2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Conducting Public Health
Research Through the Field Epidemiology
and Laboratory Training Programs (FETPs/
FELTPs), FOA GH11–001, initial review.’’
Contact Person for More Information:
Diana Bartlett, M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road, N.E., MS–
D72 (attn: Christine Morrison), Atlanta,
Georgia 30333, Telephone: (404) 639–4938,
E-mail dbartlett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–3709 Filed 2–17–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Clinical Laboratory Improvement
Advisory Committee
Correction: This notice was published
in the Federal Register on January 31,
2011, Volume 76, Number 20, page
5379. The location of the meeting has
changed as follows:
BILLING CODE 4163–18–P
Jkt 223001
[FR Doc. 2011–3708 Filed 2–17–11; 8:45 am]
Centers for Disease Control and
Prevention
[FR Doc. 2011–3654 Filed 2–17–11; 8:45 am]
13:57 Feb 17, 2011
Time and Date: 1 p.m.–4 p.m., March 31,
2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of the ‘‘National Spina Bifida
Patient Registry—Clinic Demonstration
Project (U01), FOA DD11–001, initial
review.’’
Contact Person for More Information:
Hylan D. Shoob, PhD, M.S.P.H., Scientific
Review Officer, Office of the Associate
Director for Science, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop D–72,
Atlanta, GA 30333, Telephone: (404) 639–
4796, E-mail: hshoob@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
Dated: February 9, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
VerDate Mar<15>2010
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\18FEN1.SGM
18FEN1
Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices
Place: DoubleTree Hotel Atlanta
Buckhead, 3342 Peachtree Road, NE.,
Piedmont Room, Atlanta, Georgia
30326.
Contact Person for Additional
Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch,
Division of Laboratory Science and
Standards, Laboratory Science, Policy
and Practice Program Office, Office of
Surveillance, Epidemiology and
Laboratory Services, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., Mailstop F–11, Atlanta,
Georgia 30333; telephone (404) 498–
2741; fax (404) 498–2219; or via e-mail
at Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for the Centers
for Disease Control and Prevention and
the Agency for Toxic Substances and
Disease Registry.
Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–3707 Filed 2–17–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10251]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
13:57 Feb 17, 2011
Jkt 223001
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Integrated
Medicare and Medicaid State Plan
Preprint; Form No.: CMS–10251 (OMB#:
0938–1047); Use: The Integrated Care
Preprint is an optional tool for use by
States to highlight the arrangements
provided between the State and
Medicare Advantage Special Needs
Plans that are also providing Medicaid
services. The preprint also provides the
opportunity for States to confirm that
their integrated care model complies
with Federal statutory and regulatory
requirements. State Medicaid Agencies
may complete the preprint and CMS
will review the information provided to
determine if the State has properly
completed and explained their
integrated care arrangements and that
the appropriate assurances have been
met; Frequency: Once; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 56; Total
Annual Responses: 10; Total Annual
Hours: 200. (For policy questions
regarding this collection contact Mary
Pat Farkas at 410–786–5731. For all
other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
e-mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office at 410–786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by April 19, 2011:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
9579
Security Boulevard, Baltimore,
Maryland 21244–1850.
Martique Jones,
Director, Regulations Development Group,
Division B, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2011–3749 Filed 2–17–11; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–21 and –21B,
CMS–37, CMS–64, CMS–10098, CMS–10106,
CMS–10120, CMS–10292, and CMS–10220]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: CMS–21
(Quarterly Children’s Health Insurance
Program (CHIP) Statement of
Expenditures for the Title XXI Program)
and CMS–21B (State Children’s Health
Insurance Program Budget Report for
the Title XXI Program State Plan
Expenditures); Use: Forms CMS–21 and
–21B provide CMS with the information
necessary to issue quarterly grant
awards, monitor current year
expenditure levels, determine the
allowability of State claims for
reimbursement, develop CHIP financial
management information, provide for
State reporting of waiver expenditures,
and ensure that the Federally
AGENCY:
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Pages 9578-9579]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3707]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee
Correction: This notice was published in the Federal Register on
January 31, 2011, Volume 76, Number 20, page 5379. The location of the
meeting has changed as follows:
[[Page 9579]]
Place: DoubleTree Hotel Atlanta Buckhead, 3342 Peachtree Road, NE.,
Piedmont Room, Atlanta, Georgia 30326.
Contact Person for Additional Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch, Division of Laboratory Science
and Standards, Laboratory Science, Policy and Practice Program Office,
Office of Surveillance, Epidemiology and Laboratory Services, Centers
for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop F-
11, Atlanta, Georgia 30333; telephone (404) 498-2741; fax (404) 498-
2219; or via e-mail at Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-3707 Filed 2-17-11; 8:45 am]
BILLING CODE 4163-18-P
